BlackBixon Partners with redONE in Marketing Push for Ni Hsin Resources’ F&B Business
KUALA LUMPUR, Mar 10, 2021 – (ACN Newswire) – BlackBixon Sdn Bhd (“BlackBixon”), the food…
Month: March 2021
AppsFlyer Promotes Sanjay Trisal As New General Manager of India, Southeast Asia, and Australia, New Zealand, To Strengthen Regional Collaboration
SINGAPORE, Mar 10, 2021 – (ACN Newswire) – Today, AppsFlyer, the global attribution and marketing…
Strategy Analytics: 71% of Smartphones Sold Globally in 2021 will be AI Powered
Artificial Intelligence Now Powers the Majority of Smartphones BOSTON–(BUSINESS WIRE)–Strategy Analytics in a newly published…
Covert Code Trying To Run in Memory is Blocked by New Sophos Protection Against “Heap-Heap” Permission Violations
“Dynamic Shellcode Protection” is Designed to Expose Fileless Malware, Ransomware and Remote Access Agents “Dynamic…
Yew Bio-Pharm Group Announces New Cosmetic Subsidiary
EL MONTE, California, March 09, 2021 (GLOBE NEWSWIRE) — Yew Bio-Pharm Group, Inc. (OTCQB:YEWB) (“YEWB”…
Total number of shares and voting rights in Zealand Pharma at February 28, 2021
Company announcement – No. 11/ 2021 Total number of shares and voting rights in Zealand…
Better Choice Company Announces $25.6 Million of Aggregate Minimum Purchases with its Asian Distribution Partners
Better Choice Continues Its Rapid Expansion of the Halo Brand in Asia NEW YORK, March…
TRACON Pharmaceuticals to Present at the Oppenheimer 31st Annual Healthcare Conference
SAN DIEGO, March 09, 2021 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage…
4D Molecular Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial of 4D-310 for the Treatment of Fabry Disease
EMERYVILLE, Calif., March 09, 2021 (GLOBE NEWSWIRE) — 4D Molecular Therapeutics (Nasdaq: 4DMT), a clinical-stage…
Applied Molecular Transport to Present at Oppenheimer 31st Annual Healthcare Conference
SOUTH SAN FRANCISCO, Calif., March 09, 2021 (GLOBE NEWSWIRE) — Applied Molecular Transport Inc. (Nasdaq:…
Rhythm Pharmaceuticals Announces Late-Breaking Data Presentations at ENDO 2021
BOSTON, March 09, 2021 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company…
Cue Biopharma to Host Business Update Call and Webcast
CAMBRIDGE, Mass., March 09, 2021 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (NASDAQ: CUE), a clinical-stage…
IMMUTEP SECURES SECOND UNITED STATES PATENT GRANT FOR EFTILAGIMOD ALPHA IN COMBINATION WITH A PD-1 PATHWAY INHIBITOR
Sydney, AUSTRALIA, March 09, 2021 (GLOBE NEWSWIRE) —  Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep“…
Enlivex Announces Upcoming Virtual Investor Conference Participations
Nes Ziona, Israel, March 09, 2021 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the…
Neuronetics Enhances TrakStar® Cloud Patient Data Management System to Maximize Physician Efficiencies
Technology advancements to improve clinician productivity and optimize time spent with patients MALVERN, Pa., March…
ORYZON Presents vafidemstat 12-month Clinical Data From its Phase IIa Clinical Trials ETHERAL and REIMAGINE-AD in Alzheimer’s at the Virtual AD/PD-2021 Conference
ETHERAL:º Primary endpoint met: treatment with vafidemstat for 12 months was safe and well tolerated in…
Recce Pharmaceuticals Dual Lists on Frankfurt Stock Exchange
Shares now trading on major German Trading Exchanges Shares trade under code: R9Q No related…
MediPharm Labs Expands Distribution Revenue Footprint in Canada, Enters Growing Quebec Market Through New Supply Agreement
Quebec marks the Company’s 7th provincial distribution supply agreement MediPharm Labs expanded distribution footprint represents…
Nurix Therapeutics to Participate and Present at Upcoming Investor Conferences
SAN FRANCISCO, March 09, 2021 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq: NRIX), a biopharmaceutical company…
TG Therapeutics Announces Publication of Results from the UNITY-NHL Phase 2b Trial Evaluating Umbralisib Monotherapy in Patients with Relapsed or Refractory Indolent non-Hodgkin Lymphoma in the Journal of Clinical Oncology
NEW YORK, March 09, 2021 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX) today announced…